BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38177571)

  • 1. Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden.
    Chauca Strand G; Strömberg U; Forsberg A; Bonander C
    Eur J Epidemiol; 2024 Jan; 39(1):87-96. PubMed ID: 38177571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers.
    Chiu HM; Jen GH; Wang YW; Fann JC; Hsu CY; Jeng YC; Yen AM; Chiu SY; Chen SL; Hsu WF; Lee YC; Wu MS; Wu CY; Jou YY; Chen TH
    Gut; 2021 Dec; 70(12):2321-2329. PubMed ID: 33495268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic changes in the population frequency of colonoscopy following the implementation of organised bowel cancer screening: An analysis of data from Swedish registers, 2006-2015.
    Thulin T; Strömberg U; Holmén A; Hultcrantz R; Forsberg A
    J Med Screen; 2021 Sep; 28(3):244-251. PubMed ID: 32957834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening.
    Murphy CC; Sandler RS; Sanoff HK; Yang YC; Lund JL; Baron JA
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):903-909.e6. PubMed ID: 27609707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of a Six-Year Existing Screening Programme Using the Faecal Immunochemical Test in Flanders (Belgium) on Colorectal Cancer Incidence, Mortality and Survival: A Population-Based Study.
    Tran TN; Hoeck S; De Schutter H; Janssens S; Peeters M; Van Hal G
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening: a global overview of existing programmes.
    Schreuders EH; Ruco A; Rabeneck L; Schoen RE; Sung JJ; Young GP; Kuipers EJ
    Gut; 2015 Oct; 64(10):1637-49. PubMed ID: 26041752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study.
    Ali Khan U; Fallah M; Sundquist K; Sundquist J; Brenner H; Kharazmi E
    PLoS Med; 2020 Nov; 17(11):e1003431. PubMed ID: 33186354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis.
    Ding H; Lin J; Xu Z; Wang HHX; Huang L; Huang J; Wong MCS
    BMC Cancer; 2024 Mar; 24(1):365. PubMed ID: 38515013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
    Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational targeting of population groups and residential areas for colorectal cancer screening.
    Strömberg U; Peterson S; Holmén A; Holmberg E; Hultcrantz R; Martling A; Nilbert M
    Cancer Epidemiol; 2019 Jun; 60():23-30. PubMed ID: 30897387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.
    Ebner D; Kisiel J; Barnieh L; Sharma R; Smith NJ; Estes C; Vahdat V; Ozbay AB; Limburg P; Fendrick AM
    J Med Econ; 2023; 26(1):1219-1226. PubMed ID: 37752872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in changes in the incidence of colorectal cancer by age and association with screening uptake: an observational study.
    Clark GR; Anderson AS; Godfrey TG; Strachan JA; Fraser CG; Steele RJ
    BMJ Open; 2020 Sep; 10(9):e037925. PubMed ID: 32963068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.
    Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
    Lancet; 2020 Jan; 395(10218):123-131. PubMed ID: 31929014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates.
    Zorzi M; Zappa M;
    Gut; 2020 Feb; 69(2):311-316. PubMed ID: 31040168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years: A Prospective Observational Study.
    García-Albéniz X; Hsu J; Bretthauer M; Hernán MA
    Ann Intern Med; 2017 Jan; 166(1):18-26. PubMed ID: 27669524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculating the Starting Age for Screening in Relatives of Patients With Colorectal Cancer Based on Data From Large Nationwide Data Sets.
    Tian Y; Kharazmi E; Brenner H; Xu X; Sundquist K; Sundquist J; Fallah M
    Gastroenterology; 2020 Jul; 159(1):159-168.e3. PubMed ID: 32251666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval cancer after two rounds of a Swedish population-based screening program using gender-specific cut-off levels in fecal immunochemical test.
    Ribbing Wilén H; Blom J
    J Med Screen; 2024 Mar; 31(1):8-14. PubMed ID: 37455444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.